US prepares for potential human challenge study for COVID-19 vaccine
Government researchers are developing a strain of the virus that would be used in trials where healthy participants get infected
Company
Johnson & Johnson
NYSE:JNJ
Johnson & Johnson is a diversified healthcare products company. The company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through two segments: Pharmaceutical and MedTech.
152 stories · page 5 of 8
Johnson & Johnson slapped with $8B verdict in lawsuit over antipsychotic drug Risperdal: Media Reports
A Philadelphia jury sided with 26-year-old Nicholas Murray who argued the healthcare giant downplayed the risks of male breast growth
Buds & Duds: Cannabis stocks in the green; CB2 Insights gets boost from former Johnson & Johnson executive
Also on the move were Cannvas MedTech, Harvest Health & Recreation, Canopy Growth and Choom
Archive
NA Proactive news snapshot: Cannvas MedTech, RYAH Medtech, Constantine Metal Resources, Bragg Gaming Group …
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
CB2 Insights names former Johnson & Johnson executive to its board of directors
Peter Cummins worked for more than two decades at Johnson & Johnson in a variety of executive roles
Investments and investor services
LATE MOVERS: Netflix sinks on disappointing guidance; Qualcomm and Apple settle royalty battle
Also moving Tuesday were Bank of America, Johnson & Johnson, JB Hunt and UnitedHealth
Could psychedelic medicine be the new cannabis?
Recent developments have indicated that new treatments derived from these mind-altering substances are garnering new attention from the investment community
Coverage of Geron kicks off at BTIG with a Buy rating
BTIG analyst Thomas Shrader suggests the stock has been 'left for dead' unfairly
MeiraGTx surges on collaboration with J&J unit on retinal diseases
The arrangement calls for cooperation in clinical development and preclinical programs
Late Movers: Arconic tumbles as board decides against sale, scuttling potential deal with Apollo
Other stocks that moved included Stanley Black & Decker, eBay, Johnson & Johnson and Halliburton
Investments and investor services
EARLY MOVERS: Jack in the Box shares pop on its possible sale
Goldman Sachs shares hit by Malaysian charges; Johnson & Johnson reels from asbestos scandal
Investments and investor services
EARLY MOVERS: Neurocrine Biosciences stock slumps after Tourette drug test fails
Mallinckrodt shares fall after its painkiller treatment was declined by the US Food and Drug Administration
ShareRoot granted ASX trading halt pending capital raising announcement
The halt will remain until Friday, November 16, or when an announcement is released to the market.
Hardware & electrical equipment
ShareRoot increases the Social Science takings amid MediaConsent interest
The consumer data security provider is aiming to grow revenue and reduce spending in the coming year.
Investments and investor services
Johnson & Johnson third-quarter results beat estimates; raises guidance for 2018
Company's sterling performance relied on its pharmaceutical, consumer and medical device businesses
PRE-MARKET MOVERS: Johnson & Johnson nudges higher after it beats forecasts but UnitedHealth Group shares drop
Also in the frame in nUS pre-market deals is investment banking behemoth Goldman Sachs and Carbonite Inc
Johnson & Johnson ordered to pay US$4.7bn in damages to women in talc cancer case
The women alleged J&J knew its talc contained asbestos since the 1970s and covered up the evidence
J&J hit with US$21.7mln verdict in second talcum powder-cancer trial
The New Jersey-based health care giant lost a second trial linking baby powder use to deadly asbestos cancer
Pharma sales turbocharge Johnson & Johnson’s first-quarter earnings beat
Results exceeded Wall Street expectations for earnings and revenue
Johnson & Johnson, Imerys may face more suits related to baby powder, Reuters Says
Two companies were ordered to pay a total of US117mln